weight loss injection semaglutide Injections Kirkland & Bellevue Semaglutide Weight Loss Treatment: GLP-1

For patients with T2D at high cardiovascular risk, or with established CVD, the glucagon-like peptide-1 receptor agonists (GLP1-RA) have been shown to reduce ASCVD in cardiovascular outcome trials, while potential kidney outcomes are being explored

The goal is simple: never inject within one inch (2.5 cm) of your previous injection site, and ideally use a completely different body area each week

Notably, real-world data associate liraglutide with a strong likelihood of upper abdominal pain, showing a reporting odds ratio of 4.63

Units = (2.5 / 5) x 100 = 50 units

Patients receiving sitagliptin with metformin immediate-release and insulin had significant improvements in A1C, FPG and 2-hour PPG compared to patients receiving placebo with metformin immediate-release and insulin (Table 13)

Most patients regain weight quickly